Megumi Oikawa, Hiroki Nishiwaki, Takeshi Hasegawa, Sho Sasaki, Masahiko Yazawa, Hitoshi Miyazato, Yosuke Saka, Hideaki Shimizu, Yoshiro Fujita, Minoru Murakami, Daisuke Uchida, Hiroo Kawarazaki, Shinya Omiya, Fumihiko Sasai, Fumihiko Koiwa
INTRODUCTION: To explore the association between urate-lowering agents and reduced response to erythropoietin-stimulating agents in patients suffering from chronic kidney disease G5. METHODS: We conducted a cross-sectional, multicenter study in Japan between April and June 2013, enrolling patients aged 20 years or older with an estimated glomerular filtration rate of ≤15 mL/min/1.73 m2. Exclusion criteria encompassed patients with a history of hemodialysis, peritoneal dialysis, or organ transplantation...
February 9, 2024: Nephron